Is Vilazodone registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 3 valid registrations of Vilazodone, including Vizoden (20 mg, Film-coated tablet, SAR 69.20); Vizoden (40 mg, Film-coated tablet, SAR 138.45); Vizoden (10 mg, Film-coated tablet, SAR 34.60).

Is Vilazodone approved by the US FDA?

Drugs@FDA lists 6 application product lines for Vilazodone, including VIIBRYD (Prescription); VILAZODONE HYDROCHLORIDE (Prescription); VILAZODONE HYDROCHLORIDE (Prescription); VILAZODONE HYDROCHLORIDE (Prescription); VILAZODONE HYDROCHLORIDE (Prescription).

Are there safety signals or safety updates for Vilazodone?

US FDA: 1 entry (latest 2024-04-19).

Active substance

Vilazodone

SFDA 3
US FDA 6
Health Canada 6
US price lines 6
Safety 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Vizoden	20 mg	Film-coated tablet · Oral use	30 Bottle	SAR 69.20	Generic · Prescription	MS Pharma Saudi (MSPS)	Valid
Vizoden	40 mg	Film-coated tablet · Oral use	30 Bottle	SAR 138.45	Generic · Prescription	MS Pharma Saudi (MSPS)	Valid
Vizoden	10 mg	Film-coated tablet · Oral use	30 Bottle	SAR 34.60	Generic · Prescription	MS Pharma Saudi (MSPS)	Valid

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
VIIBRYD	10MG; 20MG; 40MG	tablet · oral	ABBVIE	Prescription	21 Jan 2011
VILAZODONE HYDROCHLORIDE	10MG; 20MG; 40MG	tablet · oral	TEVA PHARMS USA	Prescription	30 Sep 2019
VILAZODONE HYDROCHLORIDE	10MG; 20MG; 40MG	tablet · oral	ALEMBIC	Prescription	10 Jan 2020
VILAZODONE HYDROCHLORIDE	10MG; 40MG; 20MG	tablet · oral	INVAGEN PHARMS	Prescription	7 Apr 2021
VILAZODONE HYDROCHLORIDE	10MG; 20MG; 40MG	tablet · oral	ACCORD HLTHCARE	Prescription	27 Apr 2021
VILAZODONE HYDROCHLORIDE	10MG; 20MG; 40MG	tablet · oral	APOTEX	Prescription	7 Jul 2023

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
APO-VILAZODONE	02551810	10 MG	TABLET · ORAL	APOTEX INC
APO-VILAZODONE	02551829	20 MG	TABLET · ORAL	APOTEX INC
APO-VILAZODONE	02551837	40 MG	TABLET · ORAL	APOTEX INC
VIIBRYD	02443724	10 MG	TABLET · ORAL	ABBVIE CORPORATION
VIIBRYD	02443732	20 MG	TABLET · ORAL	ABBVIE CORPORATION
VIIBRYD	02443740	40 MG	TABLET · ORAL	ABBVIE CORPORATION

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
US NADAC	VIIBRYD 10 MG TABLET	$12.17418	per EA	23 Sep 2026
US NADAC	VIIBRYD 20 MG TABLET	$12.18069	per EA	23 Sep 2026
US NADAC	VIIBRYD 40 MG TABLET	$12.19239	per EA	23 Sep 2026
US NADAC	VILAZODONE HCL 10 MG TABLET	$0.73165	per EA	23 Sep 2026
US NADAC	VILAZODONE HCL 20 MG TABLET	$0.70558	per EA	23 Sep 2026
US NADAC	VILAZODONE HCL 40 MG TABLET	$0.83998	per EA	23 Sep 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Safety signals and safety-related labeling changes

US FDA 19 Apr 2024 VIIBRYD — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide

All safety entries for vilazodone →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.